Search

Your search keyword '"Smallridge, Robert C"' showing total 495 results
Start Over Author "Smallridge, Robert C"
495 results on '"Smallridge, Robert C"'

4. BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression.

Author

Sigarteu Chindris, Ana-Maria, Rivera, Michael, Ma, Yaohua, Nair, Asha, Liu, Yi, Wang, Xue, Necela, Brian M., Kachergus, Jennifer M., Casler, John D., Brett, Christopher, Rivas Mejia, Ana M., Bernet, Victor J., Copland III, John A., Knutson, Keith L., Thompson, E. Aubrey, and Smallridge, Robert C.

Subjects
GENE silencing, THYROID cancer, IMMUNOSUPPRESSION, CELL populations, BRAF genes
Abstract

Introduction: BRAFV600E mutation (BRAFmut) is common in papillary thyroid cancer (PTC), and most patients have an excellent outcome. However, a TERT-promoter mutation (pTERTmut) in the presence of BRAFmut (BRAFmutpTERTmut) has been demonstrated to confer a more aggressive behavior to PTC. Lymphocytic infiltration is often present in PTC. In this study, we sought to decipher the relationship between the BRAF and pTERT mutations and immune gene dysregulation in tumor samples from a cohort of 147 samples of PTC. Methods: The abundance of 770 immune gene transcripts was determined by multiprex capture/detection and digital counting of mRNA transcripts using the NanoString nCounter® PanCancer Immune Profiling Panel. Results: We identified 40 immune transcripts differentially expressed in BRAFmutpTERTmut vs BRAFmutpTERT wildtype (pTERTwt) (P <0.05). Transcripts induced by BRAFmut alone were significantly repressed in BRAFmutpTERTmut samples, such as genes expressed by lymphoid cells, antigen-presenting cells, and cytotoxic cells, including chemokines, cytokines, checkpoint control proteins, interferon downstream markers, TNF superfamily proteins and BMP markers. A validation analysis using 444 samples from The Cancer Genome Atlas (TCGA) PTC dataset yielded similar results. Deconvolution analysis confirmed differences in the immune cell populations such as increased presence of M2 macrophages in the BRAFmutpTERTmut Mayo cohort and a lower abundance of M1 macrophages in the BRAFmutpTERTmut TCGA cohort compared to BRAFmutpTERTwt. Most of the immune gene pathways were enriched in the BRAFmutpTERTwt tumors in both Mayo and TCGA cohorts but not in BRAFmutpTERTmut. BRAFmutpTERTwt had higher stromal lymphocytes infiltration as compared to BRAFwtpTERTwt tumors, corroborating the transcriptomic findings. Discussion: To our knowledge this is the first report of a potential link between TERT and the immune microenvironment, offering an explanation for the aggressive nature of BRAFmutpTERTmut PTC. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. Anaplastic Thyroid Carcinoma, Version 2.2015.

Author

Haddad, Robert I, Lydiatt, William M, Ball, Douglas W, Busaidy, Naifa Lamki, Byrd, David, Callender, Glenda, Dickson, Paxton, Duh, Quan-Yang, Ehya, Hormoz, Haymart, Megan, Hoh, Carl, Hunt, Jason P, Iagaru, Andrei, Kandeel, Fouad, Kopp, Peter, Lamonica, Dominick M, McCaffrey, Judith C, Moley, Jeffrey F, Parks, Lee, Raeburn, Christopher D, Ridge, John A, Ringel, Matthew D, Scheri, Randall P, Shah, Jatin P, Smallridge, Robert C, Sturgeon, Cord, Wang, Thomas N, Wirth, Lori J, Hoffmann, Karin G, and Hughes, Miranda

Subjects
Rare Diseases, Cancer, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Docetaxel, Doxorubicin, Humans, Paclitaxel, Radiotherapy, Intensity-Modulated, Taxoids, Thyroid Carcinoma, Anaplastic, Thyroid Neoplasms, Thyroidectomy, Oncology & Carcinogenesis
Abstract

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were made to the systemic therapy recommendations for the 2015 update. Dosages and frequency of administration are now provided, docetaxel/doxorubicin regimens were added, and single-agent cisplatin was deleted because it is not recommended for patients with advanced or metastatic anaplastic thyroid cancer.

Published
2015

8. Optimized CART Cell Therapy for Metastatic Aggressive Thyroid Cancer

Author

Gleba, Justyna J., primary, Siegler, Elizabeth L., additional, Manriquez-Roman, Claudia, additional, Huynh, Truc N., additional, Mai, Long K., additional, Miller, James L., additional, Miller, Erin E., additional, Pawlush, Matthew L., additional, Demirer, Aylin Alasonyalilar, additional, Kimball, Brooke L., additional, Tapper, Erin E., additional, Sakemura, R. Leo, additional, Stewart, Carli M., additional, Can, Ismail, additional, Sirpilla, Olivia L., additional, Feigin, Jennifer M., additional, Yun, Kun, additional, Gutierrez Ruiz, Omar L., additional, Xia, Hong, additional, Torghabeh, Mehrdad Hefazi, additional, Schick, Kendall J., additional, Ogbodo, Ekene J., additional, Olivier, Gloria, additional, Qiu, Yushi, additional, Tun, Han W., additional, Smallridge, Robert C., additional, Zubair, Abba, additional, Copland, John A., additional, and Kenderian, Saad S., additional

Published
2024
Full Text
View/download PDF

15. Active Surveillance for Papillary Thyroid Microcarcinoma: New Challenges and Opportunities for The Health Care System

Author

Haser, Grace C., Tuttle, R. Michael, Su, Henry K., Alon, Eran E., Bergman, Donald, Bernet, Victor, Brett, Elise, Cobin, Rhoda, Dewey, Eliza H., Doherty, Gerard, Dos Reis, Laura L., Harris, Jeffrey, Klopper, Joshua, Lee, Stephanie L., Levine, Robert A., Lepore, Stephen J., Likhterov, Ilya, Lupo, Mark A., Machac, Josef, Mechanick, Jeffrey I., Mehra, Saral, Milas, Mira, Orloff, Lisa A., Randolph, Gregory, Revenson, Tracey A., Roberts, Katherine J., Ross, Douglas S., Rowe, Meghan E., Smallridge, Robert C., Terris, David, Tufano, Ralph P., and Urken, Mark L.

Published
2016
Full Text
View/download PDF

19. Abstract 5074: Addition of MAPK inhibitors to prime and sensitize poorly differentiated thyroid cancers as a strategy to improve TSHR-CART cell therapy antitumor activity

Author

Roman, Claudia Manriquez, primary, Schick, Kendall J., additional, Gleba, Justyna J., additional, Huynh, Truc N., additional, Siegler, Elizabeth L., additional, Miller, James L., additional, Demirer, Aylin Alasonyalilar, additional, Pawlush, Matthew L., additional, Biligili, Ahmet, additional, Mai, Long K., additional, Tapper, Erin, additional, Sakemura, Leo R., additional, Cox, Michelle J., additional, Stewart, Carli M., additional, Can, Ismail, additional, Ogbodo, Ekene J., additional, Cui, Gaofeng, additional, Mer, Georges, additional, Olivier, Gloria R., additional, Qiu, Yushi, additional, Smallridge, Robert C., additional, Abba, Zubair C., additional, Tun, Han W., additional, Copland, John A., additional, and Kenderian, Saad S., additional

Published
2023
Full Text
View/download PDF

20. Supplementary Figures S1-S10 from Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies

Author

Landa, Iñigo, primary, Pozdeyev, Nikita, primary, Korch, Christopher, primary, Marlow, Laura A., primary, Smallridge, Robert C., primary, Copland, John A., primary, Henderson, Ying C., primary, Lai, Stephen Y., primary, Clayman, Gary L., primary, Onoda, Naoyoshi, primary, Tan, Aik Choon, primary, Garcia-Rendueles, Maria E.R., primary, Knauf, Jeffrey A., primary, Haugen, Bryan R., primary, Fagin, James A., primary, and Schweppe, Rebecca E., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Tables S1-S12 from Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies

Author

Landa, Iñigo, primary, Pozdeyev, Nikita, primary, Korch, Christopher, primary, Marlow, Laura A., primary, Smallridge, Robert C., primary, Copland, John A., primary, Henderson, Ying C., primary, Lai, Stephen Y., primary, Clayman, Gary L., primary, Onoda, Naoyoshi, primary, Tan, Aik Choon, primary, Garcia-Rendueles, Maria E.R., primary, Knauf, Jeffrey A., primary, Haugen, Bryan R., primary, Fagin, James A., primary, and Schweppe, Rebecca E., primary

Published
2023
Full Text
View/download PDF

22. Data from Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth

Author

Marlow, Laura A., primary, Reynolds, Lisa A., primary, Cleland, Alan S., primary, Cooper, Simon J., primary, Gumz, Michelle L., primary, Kurakata, Shinichi, primary, Fujiwara, Kosaku, primary, Zhang, Ying, primary, Sebo, Thomas, primary, Grant, Clive, primary, McIver, Bryan, primary, Wadsworth, J. Trad, primary, Radisky, Derek C., primary, Smallridge, Robert C., primary, and Copland, John A., primary

Published
2023
Full Text
View/download PDF

23. Supplemental Figure 1 from miR30a Inhibits LOX Expression and Anaplastic Thyroid Cancer Progression

Author

Boufraqech, Myriem, primary, Nilubol, Naris, primary, Zhang, Lisa, primary, Gara, Sudheer Kumar, primary, Sadowski, Samira M., primary, Mehta, Amit, primary, He, Mei, primary, Davis, Sean, primary, Dreiling, Jennifer, primary, Copland, John A., primary, Smallridge, Robert C., primary, Quezado, Martha M., primary, and Kebebew, Electron, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure Legends 1-3 from Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth

Author

Marlow, Laura A., primary, Reynolds, Lisa A., primary, Cleland, Alan S., primary, Cooper, Simon J., primary, Gumz, Michelle L., primary, Kurakata, Shinichi, primary, Fujiwara, Kosaku, primary, Zhang, Ying, primary, Sebo, Thomas, primary, Grant, Clive, primary, McIver, Bryan, primary, Wadsworth, J. Trad, primary, Radisky, Derek C., primary, Smallridge, Robert C., primary, and Copland, John A., primary

Published
2023
Full Text
View/download PDF

26. Supplemental Figure 3 from miR30a Inhibits LOX Expression and Anaplastic Thyroid Cancer Progression

Author

Boufraqech, Myriem, primary, Nilubol, Naris, primary, Zhang, Lisa, primary, Gara, Sudheer Kumar, primary, Sadowski, Samira M., primary, Mehta, Amit, primary, He, Mei, primary, Davis, Sean, primary, Dreiling, Jennifer, primary, Copland, John A., primary, Smallridge, Robert C., primary, Quezado, Martha M., primary, and Kebebew, Electron, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure 1 from Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth

Author

Marlow, Laura A., primary, Reynolds, Lisa A., primary, Cleland, Alan S., primary, Cooper, Simon J., primary, Gumz, Michelle L., primary, Kurakata, Shinichi, primary, Fujiwara, Kosaku, primary, Zhang, Ying, primary, Sebo, Thomas, primary, Grant, Clive, primary, McIver, Bryan, primary, Wadsworth, J. Trad, primary, Radisky, Derek C., primary, Smallridge, Robert C., primary, and Copland, John A., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 3 from Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth

Author

Marlow, Laura A., primary, Reynolds, Lisa A., primary, Cleland, Alan S., primary, Cooper, Simon J., primary, Gumz, Michelle L., primary, Kurakata, Shinichi, primary, Fujiwara, Kosaku, primary, Zhang, Ying, primary, Sebo, Thomas, primary, Grant, Clive, primary, McIver, Bryan, primary, Wadsworth, J. Trad, primary, Radisky, Derek C., primary, Smallridge, Robert C., primary, and Copland, John A., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure 2 from Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth

Author

Marlow, Laura A., primary, Reynolds, Lisa A., primary, Cleland, Alan S., primary, Cooper, Simon J., primary, Gumz, Michelle L., primary, Kurakata, Shinichi, primary, Fujiwara, Kosaku, primary, Zhang, Ying, primary, Sebo, Thomas, primary, Grant, Clive, primary, McIver, Bryan, primary, Wadsworth, J. Trad, primary, Radisky, Derek C., primary, Smallridge, Robert C., primary, and Copland, John A., primary

Published
2023
Full Text
View/download PDF

31. Supplemental Figure 2 from miR30a Inhibits LOX Expression and Anaplastic Thyroid Cancer Progression

Author

Boufraqech, Myriem, primary, Nilubol, Naris, primary, Zhang, Lisa, primary, Gara, Sudheer Kumar, primary, Sadowski, Samira M., primary, Mehta, Amit, primary, He, Mei, primary, Davis, Sean, primary, Dreiling, Jennifer, primary, Copland, John A., primary, Smallridge, Robert C., primary, Quezado, Martha M., primary, and Kebebew, Electron, primary

Published
2023
Full Text
View/download PDF

32. Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Author

Agrawal, Nishant, Akbani, Rehan, Aksoy, B. Arman, Ally, Adrian, Arachchi, Harindra, Asa, Sylvia L., Auman, J. Todd, Balasundaram, Miruna, Balu, Saianand, Baylin, Stephen B., Behera, Madhusmita, Bernard, Brady, Beroukhim, Rameen, Bishop, Justin A., Black, Aaron D., Bodenheimer, Tom, Boice, Lori, Bootwalla, Moiz S., Bowen, Jay, Bowlby, Reanne, Bristow, Christopher A., Brookens, Robin, Brooks, Denise, Bryant, Robert, Buda, Elizabeth, Butterfield, Yaron S.N., Carling, Tobias, Carlsen, Rebecca, Carter, Scott L., Carty, Sally E., Chan, Timothy A., Chen, Amy Y., Cherniack, Andrew D., Cheung, Dorothy, Chin, Lynda, Cho, Juok, Chu, Andy, Chuah, Eric, Cibulskis, Kristian, Ciriello, Giovanni, Clarke, Amanda, Clayman, Gary L., Cope, Leslie, Copland, John A., Covington, Kyle, Danilova, Ludmila, Davidsen, Tanja, Demchok, John A., DiCara, Daniel, Dhalla, Noreen, Dhir, Rajiv, Dookran, Sheliann S., Dresdner, Gideon, Eldridge, Jonathan, Eley, Greg, El-Naggar, Adel K., Eng, Stephanie, Fagin, James A., Fennell, Timothy, Ferris, Robert L., Fisher, Sheila, Frazer, Scott, Frick, Jessica, Gabriel, Stacey B., Ganly, Ian, Gao, Jianjiong, Garraway, Levi A., Gastier-Foster, Julie M., Getz, Gad, Gehlenborg, Nils, Ghossein, Ronald, Gibbs, Richard A., Giordano, Thomas J., Gomez-Hernandez, Karen, Grimsby, Jonna, Gross, Benjamin, Guin, Ranabir, Hadjipanayis, Angela, Harper, Hollie A., Hayes, D. Neil, Heiman, David I., Herman, James G., Hoadley, Katherine A., Hofree, Matan, Holt, Robert A., Hoyle, Alan P., Huang, Franklin W., Huang, Mei, Hutter, Carolyn M., Ideker, Trey, Iype, Lisa, Jacobsen, Anders, Jefferys, Stuart R., Jones, Corbin D., Jones, Steven J.M., Kasaian, Katayoon, Kebebew, Electron, Khuri, Fadlo R., Kim, Jaegil, Kramer, Roger, Kreisberg, Richard, Kucherlapati, Raju, Kwiatkowski, David J., Ladanyi, Marc, Lai, Phillip H., Laird, Peter W., Lander, Eric, Lawrence, Michael S., Lee, Darlene, Lee, Eunjung, Lee, Semin, Lee, William, Leraas, Kristen M., Lichtenberg, Tara M., Lichtenstein, Lee, Lin, Pei, Ling, Shiyun, Liu, Jinze, Liu, Wenbin, Liu, Yingchun, LiVolsi, Virginia A., Lu, Yiling, Ma, Yussanne, Mahadeshwar, Harshad S., Marra, Marco A., Mayo, Michael, McFadden, David G., Meng, Shaowu, Meyerson, Matthew, Mieczkowski, Piotr A., Miller, Michael, Mills, Gordon, Moore, Richard A., Mose, Lisle E., Mungall, Andrew J., Murray, Bradley A., Nikiforov, Yuri E., Noble, Michael S., Ojesina, Akinyemi I., Owonikoko, Taofeek K., Ozenberger, Bradley A., Pantazi, Angeliki, Parfenov, Michael, Park, Peter J., Parker, Joel S., Paull, Evan O., Pedamallu, Chandra Sekhar, Perou, Charles M., Prins, Jan F., Protopopov, Alexei, Ramalingam, Suresh S., Ramirez, Nilsa C., Ramirez, Ricardo, Raphael, Benjamin J., Rathmell, W. Kimryn, Ren, Xiaojia, Reynolds, Sheila M., Rheinbay, Esther, Ringel, Matthew D., Rivera, Michael, Roach, Jeffrey, Robertson, A. Gordon, Rosenberg, Mara W., Rosenthal, Matthew, Sadeghi, Sara, Saksena, Gordon, Sander, Chris, Santoso, Netty, Schein, Jacqueline E., Schultz, Nikolaus, Schumacher, Steven E., Seethala, Raja R., Seidman, Jonathan, Senbabaoglu, Yasin, Seth, Sahil, Sharpe, Samantha, Shaw, Kenna R. Mills, Shen, John P., Shen, Ronglai, Sherman, Steven, Sheth, Margi, Shi, Yan, Shmulevich, Ilya, Sica, Gabriel L., Simons, Janae V., Sinha, Rileen, Sipahimalani, Payal, Smallridge, Robert C., Sofia, Heidi J., Soloway, Matthew G., Song, Xingzhi, Sougnez, Carrie, Stewart, Chip, Stojanov, Petar, Stuart, Joshua M., Sumer, S. Onur, Sun, Yichao, Tabak, Barbara, Tam, Angela, Tan, Donghui, Tang, Jiabin, Tarnuzzer, Roy, Taylor, Barry S., Thiessen, Nina, Thorne, Leigh, Thorsson, Vésteinn, Tuttle, R. Michael, Umbricht, Christopher B., Van Den Berg, David J., Vandin, Fabio, Veluvolu, Umadevi, Verhaak, Roel G.W., Vinco, Michelle, Voet, Doug, Walter, Vonn, Wang, Zhining, Waring, Scot, Weinberger, Paul M., Weinhold, Nils, Weinstein, John N., Weisenberger, Daniel J., Wheeler, David, Wilkerson, Matthew D., Wilson, Jocelyn, Williams, Michelle, Winer, Daniel A., Wise, Lisa, Wu, Junyuan, Xi, Liu, Xu, Andrew W., Yang, Liming, Yang, Lixing, Zack, Travis I., Zeiger, Martha A., Zeng, Dong, Zenklusen, Jean Claude, Zhao, Ni, Zhang, Hailei, Zhang, Jianhua, Zhang, Jiashan (Julia), Zhang, Wei, Zmuda, Erik, and Zou, Lihua

Published
2014
Full Text
View/download PDF

34. Evaluating new treatments for anaplastic thyroid cancer

Author

Coca-Pelaz, Andrés, primary, Rodrigo, Juan P., additional, Lopez, Fernando, additional, Shah, Jatin P., additional, Silver, Carl E., additional, Al Ghuzlan, Abir, additional, Menke-van der Houven van Oordt, C.Willemien, additional, Smallridge, Robert C., additional, Shaha, Ashok R., additional, Angelos, Peter, additional, Mendenhall, William M., additional, Piazza, Cesare, additional, Olsen, Kerry D., additional, Corry, June, additional, Tufano, Ralph P., additional, Sanabria, Alvaro, additional, Nuyts, Sandra, additional, Nathan, Cherie-Ann, additional, Vander Poorten, Vincent, additional, Dias, Fernando Luiz, additional, Suarez, Carlos, additional, Saba, Nabil F., additional, de Graaf, Pim, additional, Williams, Michelle D., additional, Rinaldo, Alessandra, additional, and Ferlito, Alfio, additional

Published
2022
Full Text
View/download PDF

36. Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer

Author

Prasongsook, Naiyarat, Kumar, Aditi, Chintakuntlawar, Ashish V, Foote, Robert L, Kasperbauer, Jan, Molina, Julian, Garces, Yolanda, Ma, Daniel, Wittich, Michelle A Neben, Rubin, Joseph, Richardson, Ronald, Morris, John, Hay, Ian, Fatourechi, Vahab, McIver, Bryan, Ryder, Mabel, Thompson, Geoffrey, Grant, Clive, Richards, Melanie, Sebo, Thomas J, Rivera, Michael, Suman, Vera, Jenkins, Sarah M, Smallridge, Robert C, and Bible, Keith C

Published
2017
Full Text
View/download PDF

38. Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

Author

Bible, Keith C, Suman, Vera J, Molina, Julian R, Smallridge, Robert C, Maples, William J, Menefee, Michael E, Rubin, Joseph, Sideras, Kostandinos, Morris, John C, III, McIver, Bryan, Burton, Jill K, Webster, Kevin P, Bieber, Carolyn, Traynor, Anne M, Flynn, Patrick J, Goh, Boon Cher, Tang, Hui, Ivy, Susan Percy, and Erlichman, Charles

Published
2010
Full Text
View/download PDF

41. MEN1 Mutations in Hürthle Cell (Oncocytic) Thyroid Carcinoma

Author

Kasaian, Katayoon, Chindris, Ana-Maria, Wiseman, Sam M., Mungall, Karen L., Zeng, Thomas, Tse, Kane, Schein, Jacqueline E., Rivera, Michael, Necela, Brian M., Kachergus, Jennifer M., Casler, John D., Mungall, Andrew J., Moore, Richard A., Marra, Marco A., Copland, John A., Thompson, E. Aubrey, Smallridge, Robert C., and Jones, Steven J. M.

Published
2015

42. Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: A multifactorial decision-making guide for the thyroid cancer care collaborative

Author

Urken, Mark L., Milas, Mira, Randolph, Gregory W., Tufano, Ralph, Bergman, Donald, Bernet, Victor, Brett, Elise M., Brierley, James D., Cobin, Rhoda, Doherty, Gerard, Klopper, Joshua, Lee, Stephanie, Machac, Josef, Mechanick, Jeffrey I., Orloff, Lisa A., Ross, Douglas, Smallridge, Robert C., Terris, David J, Clain, Jason B, Tuttle, Michael, and Eisele, David W.

Published
2015
Full Text
View/download PDF

47. Clinical and Molecular Features of Hürthle Cell Carcinoma of the Thyroid

Author

Chindris, Ana-Maria, Casler, John D., Bernet, Victor J., Rivera, Michael, Thomas, Colleen, Kachergus, Jennifer M., Necela, Brian M., Hay, Ian D., Westphal, Sydney A., Grant, Clive S., Thompson, Geoffrey B., Schlinkert, Richard T., Thompson, E. Aubrey, and Smallridge, Robert C.

Published
2015

48. A Multicenter Phase 2 Trial of Pazopanib in Metastatic and Progressive Medullary Thyroid Carcinoma: MC057H

Author

Bible, Keith C., Suman, Vera J., Molina, Julian R., Smallridge, Robert C., Maples, William J., Menefee, Michael E., Rubin, Joseph, Karlin, Nina, Sideras, Kostandinos, Morris, John C., III, McIver, Bryan, Hay, Ian, Fatourechi, Vahab, Burton, Jill K., Webster, Kevin P., Bieber, Carolyn, Traynor, Anne M., Flynn, Patrick J., Cher Goh, Boon, Isham, Crescent R., Harris, Pamela, and Erlichman, Charles

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results